-
Featured
Coronary Artery Disease: Pathways and Subtypes
Precision medicine can help answer whether or not current heart disease treatment paradigms optimally address genetic heterogeneity.
-
Featured
Hope for High-risk Coronary Artery Patients
Many patients with complex CAD are high-risk and ineligible for surgical treatment. Alternative and advanced interventions at Mass General are proving to be effective.
-
Featured
Coronary Artery Disease - Reporting & Data System (CAD-RADS)
Massachusetts General Hospital clinicians discuss a male age 55 that presents with left sided chest pain and has a history of hypertension and hyperlipidemia.
-
Assessing Heart Attack Risk With Genetics: Q&A With Akl C. Fahed, MD, MPH
Genome interpretation can augment our ability to interpret risk of heart attacks. Akl C. Fahed, MD, MPH, discusses a recent study that successfully implemented state-of-the-art genome interpretation for heart attack risk and showed that it is understandable and beneficial for people.
-
Healthy Lifestyle Linked to Less Risk of CAD in Patients With Familial Hypercholesterolemia
Akl C. Fahed, MD, MPH, Amit V. Khera, MD, MSc, and colleagues found that carriers of familial hypercholesterolemia gene variants who followed healthy lifestyle practices had minimal change in LDL cholesterol yet were at 86% less risk of coronary artery disease than carriers whose lifestyle was unhealthy.
-
Lipoprotein(a) Prognostic of CHD in Contemporary Cohort Receiving Menopausal Hormone Therapy
Michael C. Honigberg, MD, MPP, Pradeep Natarajan, MD, MMSc, and Mark Trinder, MSc, studied 88,266 participants in the UK Biobank and found no evidence that contemporary menopausal hormone therapy reduces the lipoprotein(a)-associated risk of coronary heart disease.
Coronary Artery Disease Contributors
-
Douglas E. Drachman, MD
Director, Cardiovascular Fellowship Program, Director, Interventional Cardiology Fellowship Program
Recent Article
ACC 2019: A Media Roundup
-
Farouc A. Jaffer, MD, PhD
Director, Coronary Intervention, Massachusetts General Hospital, Director, MGH Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) program, Associate Physician, MGH Cardiology, Department of Medicine
Recent Article
Reducing Post-Thrombotic Syndrome Through Reperfusion After DVT May Be Time-Sensitive
-
Hanna K. Gaggin, MD, MPH
Assistant Physician, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Review: Predicting Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
-
James Louis Januzzi, MD
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital, Hutter Family Professor of Medicine in the Field of Cardiology, Harvard Medical School
Recent Article
Virtual Randomized Trial Feasible, Demonstrates Canagliflozin Relieves Symptom Burden in HF
-
Malissa J. Wood, MD
Co-Director, Corrigan Women's Heart Health Program
Recent Article
Review: Does Patient–Physician Gender Concordance Influence Patient Perceptions or Outcomes?
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.